Compound Profile: Kamagra Ratigra
Kamagra Ratigra 100mg Cooper Pharma is a research-grade sildenafil citrate formulation developed for in-vitro laboratory investigations. As a phosphodiesterase type 5 (PDE5) inhibitor, this compound enables researchers at Stroid UK Shop to examine vasodilatory mechanisms and endothelial function pathways in controlled laboratory environments. Each tablet contains 100mg of pharmaceutical-grade sildenafil citrate, providing consistent experimental conditions for vascular research applications.
Laboratory Investigation Applications
Researchers utilise this compound to study nitric oxide signalling pathways and cyclic guanosine monophosphate (cGMP) regulation in vascular tissue samples. Laboratory investigations examine how PDE5 inhibition affects smooth muscle relaxation and blood flow dynamics in experimental models. Studies evaluate the compound’s interaction with endothelial cells and its role in vascular remodelling processes. Comparative research projects analyse sildenafil’s effects alongside other vasodilatory agents available through our PCT compounds catalogue. Advanced molecular studies investigate the compound’s influence on cellular signalling cascades and protein expression patterns. Research teams examine concentration-dependent responses and mechanistic pathways in controlled laboratory settings. Investigators study how this PDE5 inhibitor affects cardiovascular tissue function and arterial compliance parameters.
Research Specifications
| Active Compound | Sildenafil Citrate |
|---|---|
| Concentration | 100mg per tablet |
| Manufacturer | Cooper Pharma |
| CAS Number | 139755-83-2 |
| Molecular Formula | C22H30N6O4S |
| Research Classification | PDE5 Inhibitor |
| Storage Conditions | Cool, dry environment |
| Research Applications | Vascular studies, endothelial function |
Laboratory teams studying cardiovascular mechanisms often combine this research with investigations into selective androgen receptor modulators and peptide compounds to evaluate multi-pathway interactions.
Research Compliance Declaration
This product is manufactured strictly for in-vitro research purposes only and is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure proper laboratory protocols and safety measures when handling this compound.
